NCT01817894View on ClinicalTrials.gov

Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Hirsutism
Interventions
DRUG

Eflornithine cream 11.5 w/w %

Split face intervention with application of Eflornithine cream 11.5 w/w % versus no treatment for six months

Trial Locations (1)

2400

Dermatological Dep Bispebjerg Hospital, Copenhagen NV

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER

NCT01817894 - Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism | Biotech Hunter | Biotech Hunter